Breaking the bottleneck of internationalization development of traditional Chinese medicine requires excellent evidence

[market analysis of China Pharmaceutical network] Traditional Chinese medicine is an important part of Chinese culture, which has made indelible contributions to the prosperity of the Chinese nation for thousands of years With the rapid development of China's economy, the strengthening of people's health awareness, the aggravation of the aging population and other driving factors, in the past seven years, the market scale of China's large-scale health industry of traditional Chinese medicine has continued to rise, maintaining a double-digit high-speed growth According to the data, in 2017, the market scale of China's large-scale health industry of traditional Chinese medicine has reached 1750 billion yuan, with a year-on-year growth of 21.1%; it is expected that by 2020, China's large-scale health industry of traditional Chinese medicine will break through 3 trillion yuan, with an annual compound growth rate of 20% It can be seen that there is a strong potential development space for Chinese medicine industry in the future At the same time, under the background that traditional Chinese medicine is gradually recognized by the world, the pace of internationalization of traditional Chinese medicine is accelerating In October 2018, who released the international classification of diseases, which included traditional medicine, including traditional Chinese medicine, in the classification system This also means that Chinese medicine has gradually entered the international pharmaceutical system, and its role is increasingly recognized by the world But the internationalization of traditional Chinese medicine also faces many difficulties The industry believes that the development of traditional Chinese medicine industry, to break the bottleneck of international development, we need to provide excellent evidence "Without evidence, the world can't believe that traditional Chinese medicine can cure diseases We need to work hard to improve the quality of our products, and go to the world with high-quality drugs " Experts believe that it is only a matter of time before traditional Chinese medicine goes to the world In the future, traditional Chinese medicine will be more highly recognized and open up the international market In addition, traditional Chinese medicine enterprises need to pay more attention to the inheritance and innovation of traditional Chinese medicine Specifically, we should take the clinical value as the guidance, adhere to the theoretical system of traditional Chinese medicine, and combine modern science and technology, the three are closely combined, in order to develop the traditional Chinese medicine products that not only conform to the theory of traditional Chinese medicine, the mechanism of action, but also accurate, and promote the traditional Chinese medicine to the world Some Chinese medicine enterprise personnel said that it is doomed to be difficult for Chinese medicine to return to the right path and take the road of modernization "Therefore, we need to step out of the traditional Chinese medicine and Western medicine, stand at a higher level, and look at the modernization of traditional Chinese medicine from the perspective of inheritance and innovation." Some TCM enterprises also pointed out that the development of modern TCM should be oriented to consumers and society, especially to young consumers Only with modern scientific and innovative thinking and traditional historical culture can consumers accept and recognize it In general, inheritance and innovation is the constant theme of the development of traditional Chinese medicine industry, and how to realize the modernization of traditional Chinese medicine and how to make it bigger and stronger needs joint efforts and exploration in many aspects It is believed that in the aspect of modernization of traditional Chinese medicine, only after the realization of the factory process can the scale of the factory be realized For example, in the aspect of breeding and seedling raising, modern management technology can be used to improve the output of traditional Chinese medicine At a higher level, it is to cooperate with scientific research institutes in talents and technology, establish research stations and laboratories, establish high-level scientific research teams, and develop a series of products to meet the health needs of different groups of people In addition, many local pharmaceutical enterprises also choose to cooperate with multinational enterprises to complement each other's advantages and jointly promote the development of traditional Chinese medicine For example, AstraZeneca and LVYE pharmaceutical signed a new round of strategic cooperation memorandum at the "International Development Forum of traditional Chinese medicine" held recently The two sides officially announced that they had reached a strategic cooperation intention on the establishment of zhizhikang capsule, a Chinese patent medicine, in the market outside China, and accelerated the internationalization process of zhizhikang.